' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Search result
NHS Research Scotland Primary Care Network Bursary Scheme opens up ‘world of conference opportunities’
Applications are now being invited for a conference bursary which has been made available for a fourth year by the NHS Research Scotland (NRS) Primary Care Network The scheme encourages GP trainees and medical students to apply, allowing recipients to attend a national Primary Care conference and deepen their research knowledge while helping to potentially shape future clinical approaches. Th...
Good Research Practice (Non-drug Trials)
Pay by Cheque: please make out a cheque, payable to NHS GG& C Endowment Fund CG0337 and bring it with you on the day. Pay by Credit or Debit Card: can be arranged. (Please note your details will be stored in our database but not passed on to any other parties). If you have any queries in respect of your course fee, please telephone 0141 201 9324. Thank you.
Mental Health
Updated expectations for agreements used by commercial sponsors now published
The Health Research Authority (HRA) has today (Monday 28 April 2025) announced the publication of a new model Commercial Chief Investigator Agreement (mCCIA), and model Confidential Disclosure Agreements (mCDA), both of which are expected to be used without modification Announced in an edition of the organisation’s HRA Now bulletin, the guidance is expected to be of most use to Commercial Spon...
Primary Care
Ninewells Hospital recruits first patient for trial aimed at improving treatment of specific leukaemia
The University of Dundee and NHS Tayside has successfully recruited the first patient in the UK to a clinical trial that aims to improve treatments for a sub-group of patients affected by an aggressive blood cancer Led by Cardiff University, the OPTIMISE-FLT3 study officially opened for recruitment on 19 February, marking what the Co-Chief Investigators have called “a significant step forward” in evaluating new treatment strategies for FLT3-mutu...
Paediatrics
New UK clinical trials regulations signed into law — implementation period begins
New rules for running clinical trials in the UK have now been officially been signed into law The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were formally signed by Wes Streeting MP, Secretary of State for Health and Social Care yesterday. Yesterday (10 April 2025) marks the start of a 12-month implementation period before the amended regulations come fully into force on 10 April 2026. The updated regulations will soon be available on th...
Scottish study activity continues to seek answers during Bowel Cancer Awareness Month
Bowel Cancer Awareness Month (1-30 April) is encouraging the sharing of experiences and symptoms — with Scotland’s researchers supporting the drive for treatments through diverse trials More than nine in 10 people survive bowel cancer — the fourth most common type of cancer in the UK — when it is diagnosed at the earliest stage, so education on spotting the signs is vital. While Bowel Cancer UK is encouraging information sharing through t...
